In a seminal paper, a reduction in the FNDC5/irisin levels in both the hippocampus and cerebrospinal fluid of AD patients, as well as in the brain (i.e., hippocampus and cortex) of different transgenic AD-like mouse models, was shown [141]. The gene discussed is FNDC5; the disease is Alzheimer disease.